Recently, FOXA binding sites were identified in the E-cadherin promoter, and diminished FOXA1 expression was shown to result in decreased E-cadherin expression in poorly differentiated pancreatic ductal adenocarcinoma [32]. Here, FOXA1 is linked to pancreatic ductal adenocarcinoma.